BCRX
BioCryst Pharmaceuticals Inc
Price:  
8.99 
USD
Volume:  
3,116,034.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

BCRX EV/EBITDA

-180.3%
Upside

As of 2025-02-13, the EV/EBITDA ratio of BioCryst Pharmaceuticals Inc (BCRX) is -66.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BCRX's latest enterprise value is 2,598.28 mil USD. BCRX's TTM EBITDA according to its financial statements is -39.34 mil USD. Dividing these 2 quantities gives us the above BCRX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 14.6x - 17.0x 15.7x
Forward P/E multiples 17.9x - 24.6x 22.8x
Fair Price (6.96) - (6.78) (7.22)
Upside -177.4% - -175.4% -180.3%
8.99 USD
Stock Price
(7.22) USD
Fair Price

BCRX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-02-07 -64.62
2025-02-06 -64.67
2025-02-05 -64.04
2025-02-04 -61.30
2025-02-03 -58.83
2025-01-31 -60.30
2025-01-30 -60.15
2025-01-29 -60.93
2025-01-28 -60.46
2025-01-27 -60.88
2025-01-24 -58.93
2025-01-23 -59.41
2025-01-22 -58.83
2025-01-21 -58.78
2025-01-17 -57.93
2025-01-16 -55.88
2025-01-15 -56.78
2025-01-14 -56.78
2025-01-13 -60.46
2025-01-10 -59.09
2025-01-08 -61.09
2025-01-07 -61.57
2025-01-06 -59.93
2025-01-03 -59.25
2025-01-02 -59.93
2024-12-31 -58.30
2024-12-30 -58.36
2024-12-27 -59.30
2024-12-26 -59.36
2024-12-24 -59.09
2024-12-23 -59.67
2024-12-20 -58.57
2024-12-19 -57.62
2024-12-18 -57.20
2024-12-17 -58.14
2024-12-16 -57.99
2024-12-13 -58.36
2024-12-12 -58.72
2024-12-11 -60.09
2024-12-10 -60.46
2024-12-09 -59.41
2024-12-06 -58.78
2024-12-05 -59.99
2024-12-04 -57.30
2024-12-03 -56.57
2024-12-02 -57.57
2024-11-29 -58.20
2024-11-27 -58.20
2024-11-26 -58.14
2024-11-25 -56.99